  The human neurotensin 1 receptor (hNTS1) is a G protein-coupled receptor
involved in many physiological functions, including analgesia, hypothermia, and
hypotension. To gain a better understanding of which signaling pathways or
combination of pathways are linked to NTS1 activation and function, we
investigated the ability of activated hNTS1, which was stably expressed by
CHO-K1 cells, to directly engage G proteins, activate second messenger cascades
and recruit \b{eta}-arrestins. Using BRET-based biosensors, we found that
neurotensin (NT), NT(8-13) and neuromedin N (NN) activated the G{\alpha}q-,
G{\alpha}i1-, G{\alpha}oA-, and G{\alpha}13-protein signaling pathways as well
as the recruitment of \b{eta}-arrestins 1 and 2. Using pharmacological
inhibitors, we further demonstrated that all three ligands stimulated the
production of inositol phosphate and modulation of cAMP accumulation along with
ERK1/2 activation. Interestingly, despite the functional coupling to
G{\alpha}i1 and G{\alpha}oA, NT was found to produce higher levels of cAMP in
the presence of pertussis toxin, supporting that hNTS1 activation leads to cAMP
accumulation in a G{\alpha}s-dependent manner. Additionally, we demonstrated
that the full activation of ERK1/2 required signaling through both a
PTX-sensitive Gi/o-c-Src signaling pathway and PLCb-DAG-PKC-Raf-1- dependent
pathway downstream of Gq. Finally, the whole-cell integrated signatures
monitored by the cell-based surface plasmon resonance and changes in the
electrical impedance of a confluent cell monolayer led to identical phenotypic
responses between the three ligands. The characterization of the hNTS1-mediated
cellular signaling network will be helpful to accelerate the validation of
potential NTS1 biased ligands with an improved therapeutic/adverse effect
profile.
